IMC files a resale registration statement with the SEC
The statement registers over 17 million common shares issuable upon conversion of notes and warrants.
See the latest news and media coverage for IMC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical cannabis company
imcannabis.comLast updated
In short: IMC reported positive cash flow for 2025, initiated U.S. market entry strategies, and faced a Nasdaq compliance notice.
The statement registers over 17 million common shares issuable upon conversion of notes and warrants.
Revenue of $8.7 million, operating loss of $1.7 million, net loss of $2.5 million.
The company has 180 days to regain compliance; the notice does not affect current listing or trading.
Germany revenue surged over 134% to $36.3M, driving overall growth. Operating cash flow turned positive at C$4.7M, a turnaround from negative cash flow in 2024.
IM Cannabis Corp. ("IMC" or the "Company") , a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000...
"Q1 2025 is a clear inflection point for IMC," said Oren Shuster, Chief Executive Officer of IMC. "Achieving net profitability and an 87% improvement in...
TORONTO and GLIL YAM, Israel, Oct. 2, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical...
TORONTO and GLIL YAM, Israel, July 29, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical...
Track IMC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.